These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 30875987)

  • 1. The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity.
    Cerdó T; García-Santos JA; G Bermúdez M; Campoy C
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics and prebiotics, targeting obesity with functional foods.
    Hijova E
    Bratisl Lek Listy; 2021; 122(9):647-652. PubMed ID: 34463111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota in obesity and related comorbidities in children and adolescents: the role of biotics in treatment.
    Fiore G; Magenes VC; DI Profio E; Milanta C; Calcaterra V; Diamanti A; Campoy C; Zuccotti G; Verduci E
    Minerva Pediatr (Torino); 2022 Dec; 74(6):632-649. PubMed ID: 35708037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.
    Cuevas-Sierra A; Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Martinez JA
    Adv Nutr; 2019 Jan; 10(suppl_1):S17-S30. PubMed ID: 30721960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice.
    Bubnov R; Babenko L; Lazarenko L; Kryvtsova M; Shcherbakov O; Zholobak N; Golubnitschaja O; Spivak M
    EPMA J; 2019 Dec; 10(4):317-335. PubMed ID: 31832109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota in obesity and metabolic disorders.
    Sanz Y; Santacruz A; Gauffin P
    Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of weight loss program using prebiotics and probiotics on body composition, physique, and metabolic products: longitudinal intervention study.
    Hassan NE; El-Masry SA; El Shebini SM; Ahmed NH; Mehanna NS; Abdel Wahed MM; Amine D; Hashish A; Selim M; Afify MAS; Alian K
    Sci Rep; 2024 May; 14(1):10960. PubMed ID: 38744950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota and Obesity: A Role for Probiotics.
    Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal microbiota; relevance to obesity and modulation by prebiotics and probiotics.
    da Silva ST; dos Santos CA; Bressan J
    Nutr Hosp; 2013; 28(4):1039-48. PubMed ID: 23889619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M
    Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood obesity: a role for gut microbiota?
    Sanchez M; Panahi S; Tremblay A
    Int J Environ Res Public Health; 2014 Dec; 12(1):162-75. PubMed ID: 25546278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease.
    Tarantino G; Finelli C
    Future Microbiol; 2015; 10(5):889-902. PubMed ID: 26000656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
    Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
    Brahe LK; Astrup A; Larsen LH
    Adv Nutr; 2016 Jan; 7(1):90-101. PubMed ID: 26773017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective.
    Lin X; Han H; Wang N; Wang C; Qi M; Wang J; Liu G
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.